Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 14 de 14
Filter
1.
Turk J Gastroenterol ; 29(6): 664-668, 2018 11.
Article in English | MEDLINE | ID: mdl-30381274

ABSTRACT

BACKGROUND/AIMS: Liver transplantation (LT) is now the standard of care for most end-stage liver diseases. Over the next 30 years, advances in medicine and technology will greatly improve the survival rates of patients after this procedure. The aim of the present study was to analyze retrospectively the results of 1001 patients withLT. MATERIALS AND METHODS: Medical reports of 989 patients were analyzed retrospectively. Data were obtained from the patient's data chart. Descriptive statistics were used to describe continuous variables (mean, median, and standard deviation). RESULTS: A total of 1001 LTs for 989 recipients were performed at Ege University Organ Transplantation and Research Center between 1994 and 2017. Therewere 639 male and 350 female recipients. Among 1001 LTs, there were 438 deceased donors and 563 living donors. The age interval of the patients was 4 months to 71 years old. The median Model for End-Stage Liver Disease score was 20. There were 12 deceased liver donors using the split method. There were 12 cases subject to retransplantation. In living donor LT grafts, 423 right lobes, 46 left lobes, and 94 left lateral sectors were used. In the first monitoring,the total annual mortality rate was 130 cases (13%). The mortality rate in retransplantation was found to be 66%. A 1-year survival rate of 87% was generally stablished. CONCLUSION: LThas been improving consistently over the last two decades. Ege University is one of the biggest liver transplant centers in Turkey for both technical and educational perspective.


Subject(s)
End Stage Liver Disease/surgery , Liver Transplantation/mortality , Adolescent , Adult , Aged , Child , Child, Preschool , End Stage Liver Disease/etiology , End Stage Liver Disease/mortality , Female , Graft Survival , Hospitals, University/statistics & numerical data , Humans , Infant , Liver Transplantation/statistics & numerical data , Living Donors/statistics & numerical data , Male , Middle Aged , Retrospective Studies , Survival Rate , Time Factors , Treatment Outcome , Turkey , Young Adult
2.
Int J Psychiatry Clin Pract ; 22(3): 200-205, 2018 Sep.
Article in English | MEDLINE | ID: mdl-29179627

ABSTRACT

OBJECTIVE: The aim of this study was to investigate the prevalence of delirium and its association with mortality rates in elderly inpatients. METHODS: The medical records of 1435 patients over 65 years old who were treated at a regional university hospital and were referred to the university's Consultation and Liaison Psychiatry Clinic for psychological evaluation were retrospectively analyzed. Patients with and without a diagnosis of delirium were compared. The National Survival Database was used to determine mortality rates. RESULTS: The prevalence of delirium was 25.5%. The delirium group was older (p < .0001) and had a larger proportion of males (p < .0001). Mortality rate was higher in the delirium group at 1, 2, 3, 4, and 5 years (p < .0001 for all). Age, gender, lower urinary system diseases, chronic liver disease, solid hematologic malignancy, infections, and Alzheimer's disease emerged as significant parameters associated with mortality. Multivariate analysis of these parameters indicated that comorbid diseases (lower urinary system diseases, chronic liver disease, solid hematologic malignancy, infections, and Alzheimer's disease) are risk factors for mortality independent of demographic data such as age and gender. CONCLUSIONS: Independent of all other factors, delirium is associated with higher mortality risk.


Subject(s)
Delirium/epidemiology , Aged , Aged, 80 and over , Comorbidity , Cross-Sectional Studies , Delirium/mortality , Female , Humans , Male , Prevalence , Retrospective Studies , Turkey/epidemiology
3.
Asian J Psychiatr ; 30: 196-199, 2017 Dec.
Article in English | MEDLINE | ID: mdl-29121560

ABSTRACT

INTRODUCTION: Advanced age is one of the risk factors for attempting suicide. Suicide attempts are one of the reasons for elderly patients to admit emergency services. The aim of this study was to investigate the relationship between suicidal behavior and sociodemographic factors and concurrent somatic diseases. METHODS: The medical records of patients aged 60 years and over who presented to the emergency department of our university hospital for attempted suicide between the dates of January 1, 2007 and December 31, 2015 were screened retrospectively. Individuals recorded as cases of suicide on the forensic case report form were identified, the data recorded at our hospital were obtained, and telephone interviews were conducted to acquire any missing data. RESULTS: A total of 63 patients with a mean age of 65.88 years were included in the study. A large proportion of the suicide attempts occurred in the years 2014 and 2015. Overall, 23.8% of the patients had a previous history of suicide attempt. Overdose was the method in 74.6% of the suicide attempts, and 70.2% were impulsive; 63.5% of the patients had a history of psychiatric disease. The most common psychopathology was major depressive disorder. CONCLUSION: We found that suicide attempts were more common among older adults with a history of depression, that approximately one in four had previously attempted suicide, and that the majority of individuals attempting suicide chose to use their own medication.


Subject(s)
Aging , Alcoholism/epidemiology , Depressive Disorder, Major/epidemiology , Drug Overdose/epidemiology , Suicide, Attempted/statistics & numerical data , Aged , Aged, 80 and over , Bipolar Disorder/epidemiology , Dementia/epidemiology , Emergency Service, Hospital/statistics & numerical data , Female , Hospitals, University/statistics & numerical data , Humans , Male , Middle Aged , Psychotic Disorders/epidemiology , Retrospective Studies , Risk Factors , Turkey/epidemiology
4.
Tuberk Toraks ; 64(4): 289-298, 2016 Dec.
Article in English | MEDLINE | ID: mdl-28393718

ABSTRACT

Chronic obstructive pulmonary disease (COPD) is a complex disease that is associated with devastating outcomes resulting from lung involvement and several comorbidities. Comorbidities could impact on symptomology, quality of life, the complications, the management, economic burden and the mortality of the disease. The importance of comorbidities originates from their impact on the outcome of COPD. The most frequent comorbidities in COPD are cardiovascular, endocrinological, musculoskeletal, phycological disorders and lung cancer. Almost 50% of the COPD patients have 3 or more comorbidities. The recent Global Initiative of Obstructive Lung Disease (GOLD) Guideline suggested proactive search and the treatment of the comorbidities. However, there is no certain evidence demonstrating that active treatment of comorbidities improve the outcomes of COPD. However, it is well known that several comorbidities such as cardiovascular disease and lung cancer have greater impact on mortality caused by COPD. Several studies have shown that Charlson Comorbidity index or more recenty COPD Specific Comorbidity Index (COTE) has been found to be related with mortality of COPD. This concise review intended to summarize the most frequent comorbidities in association with their impact on COPD.


Subject(s)
Cardiovascular Diseases/complications , Lung Neoplasms/complications , Pulmonary Disease, Chronic Obstructive/complications , Quality of Life , Comorbidity , Humans
5.
Pediatr Transplant ; 16(7): 766-70, 2012 Nov.
Article in English | MEDLINE | ID: mdl-22765218

ABSTRACT

VADs have been used to provide treatment for end-stage heart failure. Parents may feel overwhelmed with the VAD regimes responsibility and be affected from this process beside children. In this study, we aimed to evaluate the depressive and anxiety symptoms of mothers of the first eight children equipped with a VAD in Turkey. The mothers of eight pediatric patients living with VADs were filled BDI and STAI at first month of VAD implantation (E.I) and secondly six months after their first evaluation (E.II). In E.I, the BDI mean score of mothers was 20.87, in E.II 14.37. STAI-S mean score was 53.37 in E.I and 43.62 in E.II. The Wilcoxon nonparametric-paired t-test revealed significant difference between baseline and end-point STAI-S scores (Z: -2.035; p: 0.042), and for BDI scores (Z, -1.965; p, 0.049). Prolonged usage of VAD may increase distress in parents. Psychiatric evaluation and support of the primary caregiver is important for the well-being of the pediatric patients.


Subject(s)
Anxiety/diagnosis , Depression/diagnosis , Heart Transplantation/methods , Heart-Assist Devices/psychology , Mothers/psychology , Adolescent , Adult , Child , Child, Preschool , Female , Humans , Infant , Male , Middle Aged , Models, Statistical , Psychiatric Status Rating Scales , Quality of Life , Treatment Outcome , Turkey
6.
Prog Neuropsychopharmacol Biol Psychiatry ; 32(6): 1459-65, 2008 Aug 01.
Article in English | MEDLINE | ID: mdl-18541357

ABSTRACT

Chronic stress is known to affect the HPA axis. The few clinical studies which have been conducted on HPA-axis function in burnout have produced inconsistent results. The etiological relationship between sBDNF and burnout has not yet been studied. The aim of the current study was to investigate the role of BDNF and HPA axis in the neurobiology of burnout. In the current study 37 clinically diagnosed burnout participants were compared with 35 healthy controls in terms of BDNF, HPA axis, burnout symptoms, depression, anxiety and psychosomatic complaints. Basal serum cortisol, sBDNF and cortisol level after 1 mg DST was sampled. We found no significant differences in terms of HPA-axis function (for basal serum cortisol, p=0.592; for cortisol level after 1 mg DST, p=0.921), but we did find lowered sBDNF levels in burnout group (88.66+/-18.15 pg/ml) as compared to healthy controls (102.18+/-20.92 pg/ml) and the difference was statistically significant (p=0.005). Logistic Regression Analysis revealed that emotional exhaustion (p=0.05), depersonalization (p=0.005) and depression (p=0.025) were significantly associated with burnout. sBDNF levels correlated negatively with emotional exhaustion (r=-,268, p=0.026), depersonalization (r=-,333, p=0.005) and correlated positively with competence (r=0.293, p=0.015) sub-scales of burnout inventory. However, there were no significant relationships between cortisol levels and sBDNF levels (r=0.80, p=0.51), depression, anxiety, psychosomatic complaints and burnout inventory. Our results suggest that low BDNF might contribute to the neurobiology of burnout syndrome and it seems to be associated with burnout symptoms including altered mood and cognitive functions.


Subject(s)
Brain-Derived Neurotrophic Factor/physiology , Burnout, Professional/metabolism , Burnout, Professional/physiopathology , Hypothalamo-Hypophyseal System/physiopathology , Adult , Brain-Derived Neurotrophic Factor/metabolism , Burnout, Professional/psychology , Case-Control Studies , Dexamethasone , Female , Humans , Hydrocortisone/blood , Logistic Models , Male , Nurses/psychology , Physicians/psychology , Pituitary Function Tests , Psychiatric Status Rating Scales , Psychology , Surveys and Questionnaires
7.
Clin Drug Investig ; 28(2): 113-20, 2008.
Article in English | MEDLINE | ID: mdl-18211119

ABSTRACT

BACKGROUND: Depression is quite common among cancer patients. It has yet to be determined which antidepressant is the most effective in cancer patients with depression. METHODS: The present study included 21 consecutive depressed oncology patients of whom 19 were followed up for 6 months. All patients initially received mirtazapine 15 mg/day and the dose was increased in the absence of significant treatment response and adverse effects. RESULTS: Depressive symptoms diminished at the end of month 1 and this improvement was maintained for the remaining 23 weeks of the study. Mean 17-item Hamilton Rating Scale for Depression (HAM-D-17) scores fell significantly from 21.4 +/- 4.9 at baseline to 6.5 +/- 3.2 at the end of the first month of treatment (p < 0.001). Among the 19 patients who were followed up, five reported at least one adverse effect during treatment; however, the vast majority of these adverse effects were described as mild to moderate. CONCLUSION: This prospective, open-label study provides preliminary evidence regarding the efficacy, safety and tolerability of mirtazapine treatment in cancer patients with depression. Relatively low doses of mirtazapine appeared to be safe and effective for treating cancer patients undergoing radiotherapy and/or chemotherapy, and the reduction in the severity of depressive symptoms was maintained until the end of the 24-week treatment period.


Subject(s)
Depressive Disorder/drug therapy , Mianserin/analogs & derivatives , Neoplasms/complications , Administration, Oral , Adult , Aged , Anorexia/diagnosis , Anorexia/drug therapy , Antidepressive Agents, Tricyclic/administration & dosage , Antidepressive Agents, Tricyclic/adverse effects , Antidepressive Agents, Tricyclic/therapeutic use , Depressive Disorder/etiology , Dose-Response Relationship, Drug , Drug Therapy, Combination , Female , Follow-Up Studies , Humans , Male , Methylphenidate/therapeutic use , Mianserin/administration & dosage , Mianserin/adverse effects , Mianserin/therapeutic use , Middle Aged , Mirtazapine , Neoplasms/drug therapy , Neoplasms/radiotherapy , Prospective Studies , Time Factors , Treatment Outcome
8.
Transplantation ; 84(4): 475-9, 2007 Aug 27.
Article in English | MEDLINE | ID: mdl-17713430

ABSTRACT

BACKGROUND: Acute liver failure (ALF) carries a high mortality unless urgent orthotopic liver transplantation (OLT) is performed on time. Live donors are utilized to treat this irreversible condition first in pediatric cases and then in adults. Herein, we aimed to report our experience with live donors for ALF in a country of a deceased donor organ donation rate is only 1.5 per million people. METHODS: Among the 245 live donor liver transplantations (LDLT) performed from June 1999 to December 2005, 14 of them (6%) were performed for ALF in 8 pediatric and 6 adult cases. Right lobes were harvested for the adult cases whereas left lateral segments were harvested for pediatric cases, except one child transplanted with a right lobe graft. The etiology of the disease was; acute hepatitis B in four cases, hepatitis A in three cases, Wilson disease two cases, autoimmune hepatitis in two cases, and was unknown in three cases. RESULTS: Three-year graft and patient survival is 79% for these series. Five of the six adult patients and six of the eight pediatric cases survived after transplantation. There was not any donor mortality or major morbidity. CONCLUSIONS: LDLT offers a safe and effective modality of treatment for ALF for both pediatric and adult patients to overcome the problem of organ shortage especially in countries where the chance of receiving an organ from a deceased donor is low.


Subject(s)
Liver Failure, Acute/surgery , Liver Transplantation/methods , Living Donors , Adult , Child , Child, Preschool , Female , Humans , Liver Transplantation/adverse effects , Liver Transplantation/ethnology , Male , Middle Aged , Postoperative Complications/etiology , Retrospective Studies , Survival Rate , Treatment Outcome , Turkey , Waiting Lists
9.
Hepatogastroenterology ; 54(75): 810-3, 2007.
Article in English | MEDLINE | ID: mdl-17591069

ABSTRACT

BACKGROUND/AIMS: Acute liver failure is a fatal condition unless an urgent liver transplantation is performed. In countries like Turkey, because of limited availability of cadaveric allografts, living donors could be used as an organ source for acute liver failure. We report our single center experience. METHODOLOGY: Six adult-to-adult right lobe living donor liver transplantations have been performed for those patients admitted with fulminant liver failure between September 2000 and April 2004. RESULTS: The age of the patients ranged between 19 and 54 years. Etiology was fulminant hepatitis B in 4 patients, Wilson's disease in 1 patient, and unknown in 1 patient. Five of 6 patients survived and are currently alive and well with a mean 30 (2-46) months follow-up. None of the survivors had neurological sequela. One patient died because of sepsis 2 months after transplantation. There was no donor mortality. CONCLUSIONS: Adult-to-adult right lobe living donor liver transplantation seems to be an effective and safe option for patients with fulminant liver failure, especially in countries with a limited number of available cadaveric donors.


Subject(s)
Liver Failure, Acute/surgery , Liver Transplantation/methods , Living Donors , Adult , Female , Humans , Male , Middle Aged , Treatment Outcome , Turkey
10.
Dig Dis Sci ; 52(2): 579-81, 2007 Feb.
Article in English | MEDLINE | ID: mdl-17211704

ABSTRACT

Although percutaneous liver biopsy (PLB) has very low mortality and morbidity rates, it often is considered painful and frightening by the patients. This study was designed to grade the intensity of pain expected before the procedure and experienced during the procedure, and whether there is any correlation between pain and the emotional state of the patient. A total of 118 consecutive patients (aged 19-68 (mean, 44) years), who were undergoing PLB for the first time, were included in the study. Visual Analogue Scale (VAS) was used before the procedure, after the procedure to grade the degree of pain expected, and the degree of the pain experienced respectively. All the patients were evaluated by a questionnaire for their personality and emotional situation by using the Minnesota Multiphasic Personality Inventory Somatization Sub-scale (MMPI-SS). Mean VAS score for expected pain before the procedure was 60+/-20 and for the pain experienced during the procedure was 22+/-16 (P < 0.0001). Although the expected pain scores of female patients were significantly higher than males (66+/-22 vs. 55+/-17; P=0.003), there was no difference between female and male patients in the experienced pain scores. The procedure of PLB is expected to be more painful than it really is by the patients, especially by females. Calming the patients by informing them about the procedure and their diseases will probably diminish the expected pain.


Subject(s)
Biopsy, Needle/adverse effects , Fear , Liver/pathology , Pain/etiology , Pain/psychology , Adult , Aged , Anesthetics, Local , Anxiety/prevention & control , Biopsy, Needle/methods , Female , Health Knowledge, Attitudes, Practice , Humans , Lidocaine , Male , Middle Aged , Pain Measurement , Patient Education as Topic , Physician-Patient Relations , Surveys and Questionnaires
11.
Agri ; 18(1): 20-5, 2006 Jan.
Article in Turkish | MEDLINE | ID: mdl-16783664

ABSTRACT

Though pain is a warning friend, it also is a life disturbing and hurting symptom. We need to consider psychological aspects of pain together with the physiological aspects, in order to be able to understand, to differentiate the etiology and to treat completely. In this review, we will discuss psychological aspects of pain patients, psychiatric patients who apply to pain clinics with pain symptoms, primarily psychological and psychiatric treatments of chronic pain patients.


Subject(s)
Pain, Intractable/psychology , Somatoform Disorders/psychology , Humans
12.
Turk Psikiyatri Derg ; 15(4): 264-75, 2004.
Article in Turkish | MEDLINE | ID: mdl-15622506

ABSTRACT

OBJECTIVE: To examine the effects of surgery type on body image, sexuality, self-esteem and marital adjustment, and to determine the most frequent sexual dysfunction seen among breast cancer survivors. METHOD: A total of 75 breast cancer survivors (50 patients underwent total mastectomy alone and 25 underwent total mastectomy with breast reconstruction), and 50 healthy volunteers were recruited. All subjects were given the Rosenberg Self-esteem Scale (RS), Body Cathexis Scale (BCS), Golombok Rust Inventory of Sexual Satisfaction (GRISS), and Dyadic Adjustment Scale (DAS) after the Structured Clinical Interview Diagnosis for DSM-III-R, Non-Patient Form (SCID-NP) had been applied. RESULTS: The mean scores obtained from GRISS and DAS were similar, but there was a significant statistical difference in terms of the mean scores of the RS and BCS between the three groups. The sexual functioning profile of the subjects was examined by transforming the subscales scores of GRISS into standardized stanine scores. A significant statistical difference in non- communication and avoidance areas of sexual relations was found between the subjects. CONCLUSION: Surgery type had no effect on sexual satisfaction or marital adjustment. Total mastectomy had a negative impact on breast perception and self-esteem. Avoidance and non-communication areas of sexual relations were the most frequent sexual dysfunctions seen among breast cancer survivors. Young patients preferred breast reconstruction more widely.


Subject(s)
Breast Neoplasms/psychology , Sexual Dysfunctions, Psychological/psychology , Adult , Body Image , Breast Neoplasms/complications , Breast Neoplasms/surgery , Case-Control Studies , Female , Humans , Mastectomy/methods , Mastectomy/psychology , Psychiatric Status Rating Scales , Self Concept
13.
Article in English | MEDLINE | ID: mdl-12551733

ABSTRACT

OBJECTIVE: Evidence indicates that valproate (VPA) may have an adverse impact on reproductive endocrine and metabolic functions in women with epilepsy. This study explores whether the association of VPA with reproductive endocrine abnormalities is applicable to women with bipolar disorder (BD) or is unique to women with epilepsy. METHODS: Thirty female patients aged 18-40 years with a DSM-IV diagnosis of BD (15 on lithium monotherapy and 15 on VPA monotherapy or VPA in combination with lithium therapy) and 15 with idiopathic generalized epilepsy (IGE) on VPA monotherapy were evaluated for reproductive endocrine functioning and metabolic parameters. RESULTS: The menarche age, mean length of menstrual cycle and mean length of menses were not significantly different between groups. None of the bipolar patients on lithium, three (20%) of the bipolar patients on VPA and seven (47%) of the epileptic patients on VPA reported menstrual disturbances. Hirsutism scores of the epilepsy group were significantly higher than those bipolar women, regardless of treatment. Serum total testosterone levels were significantly higher in patients (both with BD and with IGE) treated with VPA than in those treated with lithium. Serum FSH levels were significantly lower and LH-to-FSH ratio was significantly higher in patients with epilepsy than in patients with BD, regardless of treatment. The weight parameters and lipid values investigated did not differ significantly between the groups. CONCLUSION: The study supports the conclusion that VPA may be associated with menstrual abnormalities and increased total testosterone levels in both bipolar and epileptic patients although women with BD did not show clinical features of hyperandrogenism (menstrual abnormalities, hirsutism and truncal obesity) as did frequently as women with epilepsy.


Subject(s)
Antimanic Agents/adverse effects , Bipolar Disorder/drug therapy , Epilepsy/complications , Menstruation Disturbances/chemically induced , Metabolic Diseases/chemically induced , Valproic Acid/adverse effects , Adult , Cross-Sectional Studies , Endocrine System/drug effects , Female , Hirsutism/chemically induced , Humans , Obesity/chemically induced , Risk Factors , Testosterone/blood , Weight Gain
14.
J Affect Disord ; 70(1): 77-84, 2002 Jun.
Article in English | MEDLINE | ID: mdl-12113922

ABSTRACT

OBJECTIVE: Previous estimates of the prevalence of seasonal affective disorder (SAD) in community-based samples generally originated from western countries. We report prevalence rates in eight groups from four latitudes in Turkey. METHOD: Seasonal Pattern Assessment Questionnaire (SPAQ) was distributed to the community-based samples from eight different locations at four latitudes in Turkey. The prevalence rates of winter SAD and subsyndromal SAD (S-SAD) were estimated for the four groups at the same latitudes by using SPAQ responses. RESULTS: We distributed 3229 SPAQs, had an overall response rate of 54.16% and 1749 SPAQs were included in the analyses. Seasonality was reported as a problem by 549 subjects (31.57%) of our 1749 respondents. Prevalence of winter SAD and S-SAD are estimated as 4.86 and 8.35%, respectively, for the whole group. Prevalence rates were determined for each center and for four latitudes (two centers at the same latitude were grouped as one). In Adana-Gaziantep (lt. 37), Izmir-Elazig (lt. 38), Eskisehir-Ankara (lt. 39) and Trabzon-Edirne (lt. 41), the prevalence rates for winter SAD were 6.66, 2.25, 8.00 and 3.76%, respectively. CONCLUSIONS: Our prevalence estimates of winter SAD are similar to those found in previous community-based studies at the same latitudes; no correlation was found between latitude and prevalence of winter SAD, which could be related to the sampling methodology or to the fact that there were only 5 degrees of difference between the latitudes.


Subject(s)
Seasonal Affective Disorder/epidemiology , Adult , Female , Geography , Humans , Male , Prevalence , Turkey/epidemiology
SELECTION OF CITATIONS
SEARCH DETAIL
...